Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
Learn more today.
Charles E. Dadswell net worth and biography

Charles Dadswell Biography and Net Worth

SVP of Illumina
Charles E. Dadswell is the Senior Vice President, General Counsel, Secretary of Illumina Inc. since April 22, 2013. Mr. Dadswell joins Illumina with more than 20 years of leadership and legal experience at health care-focused technology companies. Most recently, he was Vice President, General Counsel for North and Latin America and Corporate Director of Global Intellectual Property at bioMerieux. In this role, he was responsible for a global intellectual property matters and legal matters in North and Latin America. Prior to bioMerieux, he was General Counsel of BioDelivery Sciences International, a specialty pharmaceutical company; and oversaw US intellectual property in a variety of positions with Glaxo, GlaxoWellcome and GlaxoSmithKline. Mr. Dadswell holds a LLM in patent law and trade regulation from The George Washington University Law School, a JD from the Thomas M. Cooley Law School and a bachelor's in science from Ferris State University.

What is Charles E. Dadswell's net worth?

The estimated net worth of Charles E. Dadswell is at least $1.65 million as of April 28th, 2022. Mr. Dadswell owns 7,427 shares of Illumina stock worth more than $1,645,897 as of March 22nd. This net worth estimate does not reflect any other investments that Mr. Dadswell may own. Learn More about Charles E. Dadswell's net worth.

How do I contact Charles E. Dadswell?

The corporate mailing address for Mr. Dadswell and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Charles E. Dadswell's contact information.

Has Charles E. Dadswell been buying or selling shares of Illumina?

Charles E. Dadswell has not been actively trading shares of Illumina during the last quarter. Most recently, Charles Dadswell sold 368 shares of the business's stock in a transaction on Thursday, April 28th. The shares were sold at an average price of $300.13, for a transaction totalling $110,447.84. Following the completion of the sale, the senior vice president now directly owns 7,427 shares of the company's stock, valued at $2,229,065.51. Learn More on Charles E. Dadswell's trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 14 times. They sold a total of 18,673 shares worth more than $4,563,255.41. The most recent insider tranaction occured on March, 1st when SVP Aimee L Hoyt sold 3,917 shares worth more than $779,718.02. Insiders at Illumina own 0.1% of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 3/1/2023.

Charles E. Dadswell Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2022Sell368$300.13$110,447.847,427View SEC Filing Icon  
3/28/2022Sell368$342.83$126,161.44View SEC Filing Icon  
12/22/2021Sell322$380.29$122,453.38View SEC Filing Icon  
11/22/2021Sell314$377.86$118,648.04View SEC Filing Icon  
10/22/2021Sell314$411.00$129,054.00View SEC Filing Icon  
9/22/2021Sell314$436.69$137,120.66View SEC Filing Icon  
8/23/2021Sell314$489.10$153,577.40View SEC Filing Icon  
7/22/2021Sell314$482.23$151,420.22View SEC Filing Icon  
6/22/2021Sell314$461.01$144,757.14View SEC Filing Icon  
4/22/2021Sell314$402.02$126,234.286,518View SEC Filing Icon  
3/22/2021Sell314$416.24$130,699.366,832View SEC Filing Icon  
12/1/2020Sell1,694$323.86$548,618.843,460View SEC Filing Icon  
10/1/2020Sell121$312.82$37,851.226,157View SEC Filing Icon  
8/3/2020Sell121$385.19$46,607.997,913View SEC Filing Icon  
4/1/2020Sell121$265.92$32,176.329,962View SEC Filing Icon  
12/2/2019Sell655$320.33$209,816.1511,803View SEC Filing Icon  
11/1/2019Sell193$297.28$57,375.045,069View SEC Filing Icon  
9/3/2019Sell1,220$279.88$341,453.605,386View SEC Filing Icon  
8/1/2019Sell124$300.00$37,200.00View SEC Filing Icon  
7/1/2019Sell124$371.29$46,039.96View SEC Filing Icon  
6/3/2019Sell1,220$309.70$377,834.008,006View SEC Filing Icon  
5/1/2019Sell124$311.77$38,659.488,086View SEC Filing Icon  
4/1/2019Sell124$314.45$38,991.808,210View SEC Filing Icon  
3/1/2019Sell1,220$313.93$382,994.60View SEC Filing Icon  
2/1/2019Sell124$280.11$34,733.646,879View SEC Filing Icon  
1/2/2019Sell124$294.71$36,544.047,003View SEC Filing Icon  
12/3/2018Sell566$343.57$194,460.625,606View SEC Filing Icon  
4/3/2018Sell116$230.91$26,785.567,875View SEC Filing Icon  
3/5/2018Sell145$227.17$32,939.657,991View SEC Filing Icon  
2/5/2018Sell1,610$221.45$356,534.505,581View SEC Filing Icon  
1/3/2018Sell145$224.50$32,552.507,411View SEC Filing Icon  
12/4/2017Sell145$225.33$32,672.856,388View SEC Filing Icon  
11/3/2017Sell1,609$207.88$334,478.927,217View SEC Filing Icon  
10/3/2017Sell145$202.23$29,323.35View SEC Filing Icon  
9/5/2017Sell145$205.71$29,827.95View SEC Filing Icon  
8/3/2017Sell1,609$197.00$316,973.009,037View SEC Filing Icon  
7/3/2017Sell145$174.24$25,264.8010,646View SEC Filing Icon  
6/5/2017Sell145$184.75$26,788.7510,791View SEC Filing Icon  
5/3/2017Sell1,609$187.07$300,995.6310,936View SEC Filing Icon  
2/6/2017Sell572$161.26$92,240.727,592View SEC Filing Icon  
1/10/2017Sell116$161.60$18,745.60View SEC Filing Icon  
10/4/2016Sell116$182.38$21,156.0839,900View SEC Filing Icon  
7/27/2016Sell8,632$155.00$1,337,960.0040,248View SEC Filing Icon  
4/4/2016Sell8,382$167.81$1,406,583.4254,970View SEC Filing Icon  
3/8/2016Sell8,382$155.63$1,304,490.6666,507View SEC Filing Icon  
3/7/2016Sell116$155.00$17,980.0066,507View SEC Filing Icon  
12/28/2015Sell168$188.63$31,689.8441,830View SEC Filing Icon  
11/3/2015Sell158$150.00$23,700.0040,847View SEC Filing Icon  
1/27/2015Sell224$198.90$44,553.60View SEC Filing Icon  
See Full Table

Charles E. Dadswell Buying and Selling Activity at Illumina

This chart shows Charles Dadswell's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Read More

Today's Range

Now: $221.61
Low: $218.55
High: $222.55

50 Day Range

MA: $209.65
Low: $193.75
High: $228.15

2 Week Range

Now: $221.61
Low: $173.45
High: $371.16


1,015,830 shs

Average Volume

1,458,294 shs

Market Capitalization

$35.01 billion

P/E Ratio


Dividend Yield



Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
Learn more today.